76 related articles for article (PubMed ID: 25023787)
1. The effect of smoking and timing of smoking cessation on clinical outcome in non-muscle-invasive bladder cancer.
Grotenhuis AJ; Ebben CW; Aben KK; Witjes JA; Vrieling A; Vermeulen SH; Kiemeney LA
Urol Oncol; 2015 Feb; 33(2):65.e9-17. PubMed ID: 25023787
[TBL] [Abstract][Full Text] [Related]
2. Smoking intensity and bladder cancer aggressiveness at diagnosis.
Barbosa ALA; Vermeulen SHHM; Aben KK; Grotenhuis AJ; Vrieling A; Kiemeney LA
PLoS One; 2018; 13(3):e0194039. PubMed ID: 29570711
[TBL] [Abstract][Full Text] [Related]
3. The association between smoking cessation before and after diagnosis and non-muscle-invasive bladder cancer recurrence: a prospective cohort study.
van Osch FHM; Jochems SHJ; Reulen RC; Pirrie SJ; Nekeman D; Wesselius A; James ND; Wallace DMA; Cheng KK; van Schooten FJ; Bryan RT; Zeegers MP
Cancer Causes Control; 2018 Jul; 29(7):675-683. PubMed ID: 29846846
[TBL] [Abstract][Full Text] [Related]
4. The impact of smoking on recurrence and progression of non-muscle invasive bladder cancer: a systematic review and meta-analysis.
Ślusarczyk A; Zapała P; Zapała Ł; Radziszewski P
J Cancer Res Clin Oncol; 2023 Jun; 149(6):2673-2691. PubMed ID: 36404390
[TBL] [Abstract][Full Text] [Related]
5. Prognostic relevance of urinary bladder cancer susceptibility loci.
Grotenhuis AJ; Dudek AM; Verhaegh GW; Witjes JA; Aben KK; van der Marel SL; Vermeulen SH; Kiemeney LA
PLoS One; 2014; 9(2):e89164. PubMed ID: 24586564
[TBL] [Abstract][Full Text] [Related]
6. Cigarette Smoking, Smoking Cessation, and Bladder Cancer Risk: A Pooled Analysis of 10 Cohort Studies in Japan.
Masaoka H; Matsuo K; Oze I; Kimura T; Tamakoshi A; Sugawara Y; Tsuji I; Sawada N; Tsugane S; Ito H; Wada K; Nagata C; Kitamura T; Zha L; Sakata R; Ozasa K; Lin Y; Mizoue T; Tanaka K; Abe SK; Inoue M
J Epidemiol; 2023 Nov; 33(11):582-588. PubMed ID: 36310059
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of a Dietary Intervention to Reduce Bladder Cancer Recurrence and Progression in Survivors of Non-Muscle-Invasive Bladder Cancer.
Yeary KHK; Yu H; Kuliszewski MG; Li Q; McCann SE; Pratt R; Saad-Harfouche FG; Wang Z; Clark N; Wang C; DiCarlo E; Tang L
J Natl Compr Canc Netw; 2024 Feb; 22(2):. PubMed ID: 38408431
[TBL] [Abstract][Full Text] [Related]
8. Modifying Effects of Genetic Variations on the Association Between Dietary Isothiocyanate Exposure and Non-muscle Invasive Bladder Cancer Prognosis in the Be-Well Study.
Wang Z; Kwan ML; Haque R; Singh PK; Goniewicz M; Pratt R; Lee VS; Roh JM; Ergas IJ; Cannavale KL; Loo RK; Aaronson DS; Quesenberry CP; Zhang Y; Ambrosone CB; Kushi LH; Tang L
Mol Nutr Food Res; 2024 Apr; 68(8):e2400087. PubMed ID: 38581346
[TBL] [Abstract][Full Text] [Related]
9. Smoking characteristics and years since quitting smoking of US adults diagnosed with lung and bladder cancer: A national health and nutrition examination survey analysis.
Beatrici E; Labban M; Filipas DK; Stone BV; Reis LO; Dagnino F; Lughezzani G; Buffi NM; Lipsitz SR; Clinton TN; Matulewicz RS; Trinh QD; Cole AP
Int Braz J Urol; 2024; 50(2):199-208. PubMed ID: 38386790
[TBL] [Abstract][Full Text] [Related]
10. Environmental and Occupational Exposures and Prognosis in Patients with Non-Muscle Invasive Bladder Cancer in the Be-Well Study.
Wang Z; Kwan ML; Haque R; Pratt R; Lee VS; Roh JM; Ergas IJ; Cannavale KL; Loo RK; Aaronson DS; Quesenberry CP; Ambrosone CB; Kushi LH; Tang L
Am J Epidemiol; 2023 Dec; ():. PubMed ID: 38055616
[TBL] [Abstract][Full Text] [Related]
11. Involvement of haptoglobin phenotypes and genotypes in non-muscle invasive bladder cancer: A possible prognostic marker for risk stratification.
Aghaalikhani N; Zamani M; Allameh A; Mashayekhi A; Shadpour P; Mahmoodi M; Rashtchizadeh N
EXCLI J; 2020; 19():351-359. PubMed ID: 32256273
[TBL] [Abstract][Full Text] [Related]
12. [The many urological consequences of smoking].
Grégoris A; Valerio M; Abboud AE; Grobet-Jeandin E
Rev Med Suisse; 2023 Nov; 19(852):2234-2238. PubMed ID: 38019538
[TBL] [Abstract][Full Text] [Related]
13. Clearing the Smoke: Underreporting of Smoking Status in Food and Drug Administration-Approved Bladder Cancer Therapeutic Trials.
Kay H; Matulewicz RS; Bjurlin MA
J Urol; 2024 Apr; 211(4):611-613. PubMed ID: 38299550
[No Abstract] [Full Text] [Related]
14. Smoking, ethnicity and bladder cancer - implications for public health and clinical practice.
Laukhtina E; Shariat SF
Nat Rev Urol; 2023 Nov; 20(11):643-644. PubMed ID: 37464063
[No Abstract] [Full Text] [Related]
15. Knowledge of Bladder Cancer Risk Factors Among Patients Diagnosed With Nonmuscle-invasive Bladder Cancer.
Matulewicz RS; Whiting K; Bochner BH; Ostroff JS; Furberg H
J Urol; 2023 Jan; 209(1):6-8. PubMed ID: 36194203
[No Abstract] [Full Text] [Related]
16. Office-based management of Non-Muscle Invasive Bladder Cancer (NMIBC): A position paper on current state of the art and future perspectives.
Leonardi R; Ambrosini F; Cafarelli A; Calarco A; Colombo R; Tuzzolo D; De Marco F; Ferrari G; Ludovico G; Pecoraro S; De Cobelli O; Terrone C; Mantica G
Arch Ital Urol Androl; 2024 Mar; 96(1):12404. PubMed ID: 38502027
[TBL] [Abstract][Full Text] [Related]
17. Smoking cessation after a cancer diagnosis: Commentary on special supplement in Cancer Epidemiology.
Smith J; Togawa K; Dresler C; Hawari F; Zain ZM; Stewart B; Warren GW; Sitas F
Cancer Epidemiol; 2022 Aug; 79():102210. PubMed ID: 35785684
[No Abstract] [Full Text] [Related]
18. The effect of smoking and timing of smoking cessation on clinical outcome in non-muscle-invasive bladder cancer.
Furberg H; Schoenberg M
Urol Oncol; 2015 Jan; 33(1):49. PubMed ID: 25443266
[No Abstract] [Full Text] [Related]
19. Cigarette smoking prior to first cancer and risk of second smoking-associated cancers among survivors of bladder, kidney, head and neck, and stage I lung cancers.
Shiels MS; Gibson T; Sampson J; Albanes D; Andreotti G; Beane Freeman L; Berrington de Gonzalez A; Caporaso N; Curtis RE; Elena J; Freedman ND; Robien K; Black A; Morton LM
J Clin Oncol; 2014 Dec; 32(35):3989-95. PubMed ID: 25385740
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of bladder cancer.
Malats N; Real FX
Hematol Oncol Clin North Am; 2015 Apr; 29(2):177-89, vii. PubMed ID: 25836927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
